These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25330392)

  • 21. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross verification of prescribing trends through loop evaluation of physicians, patients and medical store personnel.
    Husnain SZ; Bukhari NI; Hussain K; Babar ZU; Hashmi FK; Saleem Z; Salman M; Curley L
    BMC Health Serv Res; 2019 May; 19(1):328. PubMed ID: 31118096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence exerted on drug prescribing by patients' attitudes and expectations and by doctors' perception of such expectations: a cohort and nested case-control study.
    Lado E; Vacariza M; Fernández-González C; Gestal-Otero JJ; Figueiras A
    J Eval Clin Pract; 2008 Jun; 14(3):453-9. PubMed ID: 18373568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia.
    Workneh BD; Gebrehiwot MG; Bayo TA; Gidey MT; Belay YB; Tesfaye DM; Kassa TT
    PLoS One; 2016; 11(6):e0156795. PubMed ID: 27304215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicians and the pharmaceutical industry: is a gift ever just a gift?
    Wazana A
    JAMA; 2000 Jan; 283(3):373-80. PubMed ID: 10647801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicians, pharmaceutical sales representatives, and the cost of prescribing.
    Caudill TS; Johnson MS; Rich EC; McKinney WP
    Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of physicians who frequently see pharmaceutical sales representatives.
    Alkhateeb FM; Khanfar NM; Clauson KA
    J Hosp Mark Public Relations; 2009; 19(1):2-14. PubMed ID: 19197653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.
    Hurley MP; Stafford RS; Lane AT
    JAMA Dermatol; 2014 May; 150(5):487-93. PubMed ID: 24740450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generic medicines: Greek physicians' perceptions and prescribing practices.
    Tsiantou V; Zavras D; Kousoulakou H; Geitona M; Kyriopoulos J
    J Clin Pharm Ther; 2009 Oct; 34(5):547-54. PubMed ID: 19744010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
    Mitchell AP; Winn AN; Lund JL; Dusetzina SB
    Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing habits of Peruvian physicians and factors influencing them.
    Zárate Cárdenas E; Liosa Isenrich L
    Bull Pan Am Health Organ; 1995 Dec; 29(4):328-37. PubMed ID: 8605524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of pharmaceutical sales representatives by family physicians--does it affect the prescribing index?
    Klemenc-Ketis Z; Kersnik J
    Fam Pract; 2013 Jun; 30(3):320-4. PubMed ID: 23241163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
    Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic stewardship based on education: minor impact on knowledge, perception and attitude.
    Kjærsgaard M; Leth RA; Udupi A; Ank N
    Infect Dis (Lond); 2019 Oct; 51(10):753-763. PubMed ID: 31389732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.